← Eichor
Study identifier: NCT07415109 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Improving LDL-C Levels Through Temporal Self-regulation Theory-based, Personality-tailored Health Messages

Condition: Adherence · Preventive Health Services  ·  Sponsor: National University Health System, Singapore

PhaseNA
Planned participants3000
Who can joinAll sexes, 21 Years to 65 Years
Healthy volunteersNo

About this study

The study is meant to run parallel to the larger study, RESET. The goal of this study is to to evaluate the effectiveness of a once-off general and personality-tailored text message on GP consultation among RESET participants identified to have high LDL-C. The main question it aims to answer is: Will participants exposed to personality tailored advice have a higher adherence to GP consultation compared to the participants in the control group? Researchers will compare a personalized message to a general message (with no personalization according to patients personality type) and control group to see if the messages increase adherence. Participants are required to complete two questionnaires: one before and one after they receive their RESET results.

This description comes directly from the study's public registry record.

Talk to the study team

Jocelyn Chew  ·  +6565168687  ·  dbi-lab@nus.edu.sg

Always discuss trial participation with your own doctor first.

Locations (1)

National University of SingaporeSingapore, SingaporeRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07415109